180 related articles for article (PubMed ID: 21584634)
21. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
[TBL] [Abstract][Full Text] [Related]
22. Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors.
Uraki J; Yamakado K; Nakatsuka A; Takeda K
Eur J Radiol; 2004 Jul; 51(1):12-8. PubMed ID: 15186879
[TBL] [Abstract][Full Text] [Related]
23. Chemoembolization of extrahepatic collateral arteries for treatment of hepatocellular carcinoma in the caudate lobe of the liver.
Woo S; Kim HC; Chung JW; Jung HS; Hur S; Lee M; Jae HJ
Cardiovasc Intervent Radiol; 2015 Apr; 38(2):389-96. PubMed ID: 24934735
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
[TBL] [Abstract][Full Text] [Related]
25. Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.
Chung WS; Lee KH; Park MS; Lee YJ; Kwon J; Baek SE; Kim MJ
AJR Am J Roentgenol; 2012 Aug; 199(2):349-59. PubMed ID: 22826396
[TBL] [Abstract][Full Text] [Related]
26. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].
Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295
[TBL] [Abstract][Full Text] [Related]
29. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
[TBL] [Abstract][Full Text] [Related]
30. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.
Kato H; Kanematsu M; Kondo H; Goshima S; Matsuo M; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Jan; 19(1):76-81. PubMed ID: 14696223
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
Choi JW; Lee JM; Kim SJ; Yoon JH; Baek JH; Han JK; Choi BI
Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584
[TBL] [Abstract][Full Text] [Related]
32. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
33. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
34. Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance.
Sato K; Tanaka S; Mitsunori Y; Mogushi K; Yasen M; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S
Hepatology; 2013 Apr; 57(4):1436-47. PubMed ID: 23150500
[TBL] [Abstract][Full Text] [Related]
35. Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma?
Ramacciato G; Mercantini P; Petrucciani N; Ravaioli M; Cucchetti A; Del Gaudio M; Cescon M; Ziparo V; Pinna AD
Am Surg; 2010 Nov; 76(11):1189-97. PubMed ID: 21140683
[TBL] [Abstract][Full Text] [Related]
36. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging.
Ichikawa T; Federle MP; Grazioli L; Marsh W
Radiology; 2000 Oct; 217(1):145-51. PubMed ID: 11012437
[TBL] [Abstract][Full Text] [Related]
37. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.
Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285
[TBL] [Abstract][Full Text] [Related]
38. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression.
Park Y; Kim YS; Rhim H; Lim HK; Choi D; Lee WJ
AJR Am J Roentgenol; 2009 Sep; 193(3):757-63. PubMed ID: 19696290
[TBL] [Abstract][Full Text] [Related]
39. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
Chan AW; Tong JH; Chan SL; Lai PB; To KF
Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
[TBL] [Abstract][Full Text] [Related]
40. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
